MAPK8 and cancer: Emerging evidence implies that the persistent activation of JNKs is involved in cancer development and progression supporting the pro-oncogenic role of JNK in prostate cancer, non-small cell lung cancer, and glioblastoma, among others (Figure 5B; Luo et al., 2019; Portela et al., 2019; Xu and Hu, 2020).